Among post-menopausal women with angiographically documented coronary artery disease in this study, baseline cystatin C level was associated with worse clinical outcomes without accelerated progression of atherosclerosis.
Published in Brief:
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||